This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
40,40 €
Share price
0.00%
Change (1 day)
118.30%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Net assets
Net assets on the balance sheet as of September 2022 : €91.57 Million
According to Albireo Pharma's latest financial reports the company has €91.57 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Albireo Pharma - Net assets on balance sheet (from 2005 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2021-12-31 | $€0.15 B | 5.24% |
| 2020-12-31 | $€0.14 B | 77.18% |
| 2019-12-31 | $€83.16 M | -22.42% |
| 2018-12-31 | $€0.10 B | 97.12% |
| 2017-12-31 | $€54.38 M | 54.81% |
| 2016-12-31 | $€35.13 M | |
| 2016-09-30 | $€23.56 M | -32.95% |
| 2015-09-30 | $€35.14 M | 95.66% |
| 2014-09-30 | $€17.96 M | -25.56% |
| 2013-09-30 | $€24.12 M | 0.03% |
| 2012-09-30 | $€24.12 M | -11.61% |
| 2011-09-30 | $€27.29 M | 54.59% |
| 2010-09-30 | $€17.65 M | -48.8% |
| 2009-09-30 | $€34.48 M | -45.06% |
| 2008-09-30 | $€62.77 M | 14.98% |
| 2007-09-30 | $€54.59 M | 322.81% |
| 2006-09-30 | $€12.91 M | 2274.82% |
| 2005-09-30 | $€0.54 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | €0.22 B | 142.95% | 🇺🇸 USA |